The PPARα–leukotriene B4 pathway to inflammation control
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation is a local immune response to 'foreign' molecules, infection and injury. Leukotriene B4, a potent chemotactic agent that initiates, coordinates, sustains and amplifies the inflammatory response, is shown to be an activating ligand for the transcription factor PPARalpha. Because PPARalpha regulates the oxidative degradation of fatty acids and their derivatives, like this lipid mediator, a feedback mechanism is proposed that controls the duration of an inflammatory response and the clearance of leukotriene B4 in the liver. Thus PPARalpha offers a new route to the development of anti- or pro-inflammatory reagents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FFAs act as PPAR agonists facilitating translocation to the nucleus and dimerization to RXR [77,78].”
From Lipoprotein Lipase Regulates Microglial Lipid Droplet Accumulation (2021) · cites this paper as [77]
In the citing paper
“PPAR-α is involved in the regulation of pro-inflammatory genes, mainly by limiting cytokine expression.[109]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [109]
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Self-citation
Research works printed but not linked: 6
- Ford-Hutchinson, A. W. Crit. Rev. Immunol. 10, 1–11 (1990).
- Desvergne, B. & Wahli, W. in Inducible Transcription Vol. 1 (ed. Bæuerle, P.) 142–176 (Birkhäuser, Boston, 1995).
- Greene, M. E. et al. Gene Expr. 4, 281–299 (1995).
- Schmidt, A. et al. Mol. Endocrinol. 6, 1634–1641 (1992).
- Yu, K. et al. J. Biol. Chem. 270, 23975–23983 (1995). · DOI · Paper page
- Peters, J. M. et al. Mol. Pharmacol. 50, 67–94 (1996).
Cited by
Items 701–800 of 1,001
Palmer, C. N. A., Axén, E., Hughes, V. M., & Wolf, C. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18109 · Cited by 40
Zhang, X., Chen, L., & Hardwick, J. P. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1836 · Cited by 40
5-Lipoxygenase and human pulmonary artery endothelial cell proliferation
Walker, J. L., Loscalzo, J., & Zhang, Y. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00003.2001 · Cited by 40
“A recent study has shown that leukotriene B4 binds peroxisome proliferator-activated receptor- (PPAR ), a nuclear hormone receptor or transcription factor, and upregulates PPAR -targeted genes (16).”
BackgroundRago, B., & Fu, C. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.08.001 · Cited by 39
Duerr, G. D., Heinemann, J. C., Arnoldi, V., Feißt, A., Kley, J., Ghanem, A., Welz, A., & Dewald, O. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.03.019 · Cited by 42
Matlock, H. G., Qiu, F., Malechka, V. V., Zhou, K., Cheng, R., Benyajati, S., Whelchel, A. E., Karamichos, D., & Ma, J. (2020) · Diabetes · doi:10.2337/db19-0898 · Cited by 39
Effects of pravastatin in murine collagen-induced arthritis
Yamagata, T., Kinoshita, K., Nozaki, Y., Sugiyama, M., Ikoma, S., & Funauchi, M. (2006) · Rheumatology International · doi:10.1007/s00296-006-0270-9 · Cited by 40
Passilly, P., Schohn, H., Jannin, B., Cherkaoui‐Malki, M., Boscoboinik, D. O., Dauça, M., & Latruffe, N. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00182-3 · Cited by 44
Zacharias, H. U., Schley, G., Hochrein, J., Klein, M. S., Köberle, C., Eckardt, K., Willam, C., Oefner, P. J., & Gronwald, W. (2012) · Metabolomics · doi:10.1007/s11306-012-0479-4 · Cited by 44
“During the blood reperfusion phase after renal tissue ischemia, the lipid mediator LTB4 has been shown to activate polymorphonuclear neutrophil cells and to promote their infiltration into the postischemic kidney, where they release reactive oxygen species, proteases, elastase, myeloperoxidase, and other mediators, al…”
BackgroundInfluentialSchaefer, M. B., Pose, A., Ott, J., Hecker, M., Behnk, A., Schulz, R., Weißmann, N., Günther, A., Seeger, W., & Mayer, K. (2008) · European Respiratory Journal · doi:10.1183/09031936.00035808 · Cited by 42
Youssef, J., & Badr, M. Z. (1998) · Critical Reviews in Toxicology · doi:10.1080/10408449891344182 · Cited by 39
Rusyn, I., Bradham, C. A., Cohn, L., Schoonhoven, R., Swenberg, J. A., Brenner, D. A., & Thurman, R. G. (1999) · Carcinogenesis · doi:10.1093/carcin/20.11.2095 · Cited by 39
Andersson, Y., Majd, Z., Lefebvre, A.-M., Martin, G., Sechkin, A. V., Kosykh, V., Fruchart, J.-C., Najib, J., & Staels, B. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.1.115 · Cited by 39
Zhao, J., Sharma, Y., & Agarwal, R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199912)26:4<254::aid-mc4>3.0.co;2-d · Cited by 5
Yadetie, F., Lægreid, A., Bakke, I., Kusnierczyk, W., Komorowski, J., Waldum, H. L., & Sandvik, A. K. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00064.2003 · Cited by 40
Gray, E., Ginty, M., Kemp, K. C., Scolding, N. J., & Wilkins, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07637.x · Cited by 42
“Furthermore, it has recently been proposed that PPAR-a agonists play a role in regulating the inflammatory response (Devchand et al., 1996; Delerive et al., 1999; Chinetti et al., 2001; Cunard et al., 2002; Jones et al., 2002), with recent studies demonstrating beneficial effects of these drugs in…”
BackgroundSugar or fat: The metabolic choice of the trained heart
Ferreira, R. M., Nogueira‐Ferreira, R., Trindade, F., Vitorino, R. M. P., Powers, S. K., & Moreira‐Gonçalves, D. (2018) · Metabolism · doi:10.1016/j.metabol.2018.07.004 · Cited by 40
Li, L., Zhou, J., Wang, S., Jiang, L., Chen, X., Zhou, Y., Li, J., Shi, J., Liu, P., Shu, Z., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279770 · Cited by 42
Self-citationDelayre‐Orthez, C., Becker, J., Auwerx, J. H., Frossard, N., & Pons, F. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.040 · Cited by 38
Penning, T. D., Russell, M. A., Chen, B. B., Chen, H. Y., Liang, C.-D. D., Mahoney, M. W., Malecha, J. W., Miyashiro, J. M., Yu, S. S., Askonas, L. J., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200916 · Cited by 38
Mazzon, E., & Cuzzocrea, S. (2007) · Shock · doi:10.1097/shk.0b013e318033eb29 · Cited by 39
“In particular, it has been shown that the ear inflammation induced by leukotriene B4 or arachidonic acid, but not tissue plasminogen activator, was prolonged in PPAR KO mice (30).”
BackgroundPace, E., Profita, M., Melis, M. R., Bonanno, A., Paternò, A., Mody, C. H., Spatafora, M., Ferraro, M., Siena, L., Vignola, A. M., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02387.x · Cited by 38
IL-1 and LPS but not IL-6 inhibit differentiation and downregulate PPAR gamma in brown adipocytes
Mráček, T., Cannon, B., & Houštěk, J. (2004) · Cytokine · doi:10.1016/j.cyto.2003.12.001 · Cited by 38
Matsusue, K., Ishii, Y., Ariyoshi, N., & Oguri, K. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990104r · Cited by 38
Peroxisome Proliferator‐Activated Receptor and Retinoic X Receptor in Alcoholic Liver Disease
Mello, T., Polvani, S., & Galli, A. (2009) · PPAR Research · doi:10.1155/2009/748174 · Cited by 42
Nuclear prostaglandin receptors: role in pregnancy and parturition?
Helliwell, R. J. A., Berry, E. B. E., O’Carroll, S. J., & Mitchell, M. D. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.005 · Cited by 43
Emerging drugs in endometriosis
Mihalyi, A., Simsa, P., Mutinda, K. C., Meuleman, C., Mwenda, J. M., & D’Hooghe, T. M. (2006) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.11.3.503 · Cited by 39
“PPARs have been shown to mediate anti-inflammatory processes [153-155].”
BackgroundPharmacological Characterization of Leukotriene Receptors
Dahlén, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-9 · Cited by 38
Altering molecular mechanisms to prevent sudden arrhythmic death
Henry, P. D., & Pacifico, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10049-6 · Cited by 38
Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?
Denning, G. M., & Stoll, L. L. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20338 · Cited by 39
Li, C., Luo, Y., Zhang, W., Cai, Q., Wu, X., Tan, Z., Chen, R., Chen, Z., Wang, S., & Zhang, L. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114472 · Cited by 37
Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD
Marian, E., Baraldo, S., Visentin, A., Papi, A. A., Saetta, M. P., Fabbri, L. M., & Maestrelli, P. (2006) · CHEST Journal · doi:10.1378/chest.129.6.1523 · Cited by 37
A20 Modulates Lipid Metabolism and Energy Production to Promote Liver Regeneration
Damrauer, S. M., Studer, P., da Silva, C. G., Longo, C. R., Ramsey, H. E., Csizmadia, E., Shrikhande, G., Scali, S. T., Libermann, T. A., Bhasin, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017715 · Cited by 38
Wu, X., Peters, J. M., Gonzalez, F. J., Prasad, H. S., Rohrer, M. D., & Gimble, J. M. (2000) · Bone · doi:10.1016/s8756-3282(99)00238-0 · Cited by 40
Self-citationThe role of transcription factors in allergic inflammation
Escoubet‐Lozach, L., Glass, C. K., & Wasserman, S. I. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.128076 · Cited by 39
Martin, V., Rondé, P., Unett, D. J., Wong, A., Hoffman, T. L., Edinger, A. L., Doms, R. W., & Funk, C. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8597 · Cited by 37
15-deoxy-Δ12,14PGJ2 induces diverse biological responses via PPARγ activation in cancer cells
Claya, C. E., Namen, A. M., Fonteh, A. N., Atsumi, G., High, K. P., & Chilton, F. H. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00073-3 · Cited by 37
Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes
Moller, D. E., & Greene, D. A. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56006-4 · Cited by 38
ISG12 is a critical modulator of innate immune responses in murine models of sepsis
Uhrín, P., Perkmann, T., Binder, B. R., & Schabbauer, G. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.009 · Cited by 36
Vicente, A. M., Guillén, M. I., & Alcaraz, M. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704145 · Cited by 37
“Further studies would be necessary to elucidate the mechanism of action of LTs in this setting although previous work has suggested an anti-in¯ammatory e ect of LTB4 mediated by peroxisome proliferator-activated receptor-a activation (Devchand et al., 1996).”
BackgroundLipid metabolism orchestrates liver regeneration: an integrated metabolic network
Duan, L., Chang, Y., Dai, J., Lu, H., Zhao, W., Shen, Y., Lin, J., & Cai, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07232-5 · Cited by 39
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Han, E., Jang, S., Kim, G., Lee, Y., Choe, E. Y., Nam, C. M., & Kang, E. S. (2016) · Medicine · doi:10.1097/md.0000000000002786 · Cited by 37
Ding, C.-W., Luo, W., Zhou, J.-Y., Ma, X.-J., Chen, G., Zhou, X., & Li, D. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b15311 · Cited by 35
Regulation of peroxisome proliferator-activated receptor-α expression during lung inflammation
Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.08.001 · Cited by 35
Toyoda, T., Kamei, Y., Kato, H., Sugita, S., Takeya, M., Suganami, T., & Ogawa, Y. (2008) · Obesity · doi:10.1038/oby.2008.62 · Cited by 43
Maresin 1 attenuates pro-inflammatory reactions and ER stress in HUVECs via PPARα-mediated pathway
Jung, T. W., Park, H. S., Choi, G. H., Kim, D., Ahn, S. H., Kim, D.-S., Lee, T., & Jeong, J. H. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3392-y · Cited by 35
Kubohara, Y., Arai, A., Gokan, N., & Hosaka, K. (2007) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2007.00920.x · Cited by 35
“For example, while leukotriene B4 (LTB4) functions via the nuclear receptor, PPARα (peroxisome proliferator activated receptor-α) (Devchand et al. 1996), LTB4 induces a rise in [Ca2+]c and the inhibition of adenylate cyclase via BLT (the cell membrane-integrated receptor for LTB4) (Palmblad et al.…”
BackgroundTan, N. S., Michalik, L., Desvergne, B., & Wahli, W. (2003) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200304080-00001 · Cited by 42
Self-citationBenzo6a9pyrene diol epoxide up-regulates COX-2 expression through NF-$kappa;B in rat astrocytes
Weng, M., Hsiao, Y.-M., Chen, C.-J., Wang, J.-P., Chen, W., & Ko, J.-L. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.03.007 · Cited by 38
Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?
Bazinet, R. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371104 · Cited by 40
Ravaux, L., Denoyelle, C., Monne, C., Limon, I., Raymondjean, M., & Hadri, K. E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00623-07 · Cited by 37
5-Lipoxygenase and Leukotrienes: Transgenic Mouse and Nuclear Targeting Studies
Funk, C. D., & Chen, X. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-24 · Cited by 35
Radominska-p, A., & Chen, G. (2002) · Biochemistry · doi:10.1021/bi0121151 · Cited by 39
Peroxisome Proliferator-activated Receptors in Atherosclerosis and Inflammation—An Update
Elangbam, C. S., Tyler, R. D., & Lightfoot, R. M. (2001) · Toxicologic Pathology · doi:10.1080/019262301317052495 · Cited by 40
“Inhibition of the cyclooxygenase step of arachidonic acid metabolism by PPAR-a is another mechanism by which PPAR-a agonists appear to inhibit in ammation in endothelial cells (19).”
BackgroundInfluentialRegulation of gene expression by fatty acids
Pégorier, J. P. (1998) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199807000-00003 · Cited by 36
Pinot, F., Benveniste, I., Salaün, J., & Durst, F. (1998) · PLANT PHYSIOLOGY · doi:10.1104/pp.118.4.1481 · Cited by 35
“Proc Natl Acad Sci USA 89: 4938–4941 Devchand PR, Keller H, Peters JM, Vazquez M, Gonzales FJ, Wahli W (1996) The PPARa-leukotriene B4 pathway to inflammation control.”
BackgroundInfluentialSuruga, K., Mochizuki, K., Suzuki, R., Goda, T., & Takase, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00330.x · Cited by 35
PPARs and the Development of Type 1 Diabetes
Holm, L. J., Mønsted, M. Ø., Haupt‐Jorgensen, M., & Buschard, K. (2020) · PPAR Research · doi:10.1155/2020/6198628 · Cited by 38
“In support of this, PPARα knockout mice have prolonged inflammatory response to inflammatory agents such as arachidonic acid [59].”
BackgroundRAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury
van Neerven, S., & Mey, J. (2007) · PPAR Research · doi:10.1155/2007/29275 · Cited by 40
Watanabe, M. X., Kunisue, T., Tao, L., Kannan, K., Subramanian, A., Tanabe, S., & Iwata, H. (2010) · Environmental Toxicology and Chemistry · doi:10.1002/etc.189 · Cited by 38
Brock, T. G., Lee, Y.-J., Maydanski, E., Marburger, T. L., Luo, M., Paine, R., & Peters-Golden, M. L. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00423.2004 · Cited by 37
Role of palmitoylethanolamide (PEA) in depression: Translational evidence
Gregorio, D. D., Manchia, M., Carpiniello, B., Valtorta, F., Nobile, M., Gobbi, G., & Comai, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.117 · Cited by 36
Baumgart‐Vogt, E. (1997) · Histochemistry and Cell Biology · doi:10.1007/s004180050160 · Cited by 34
PPAR-α Expression Inversely Correlates with Inflammatory Cytokines IL-1β and TNF-α in Aging Rats
Gélinas, D. S., & McLaurin, J. (2005) · Neurochemical Research · doi:10.1007/s11064-005-8341-y · Cited by 40
“came from a report showing that arachidonic acidinduced ear swelling in PPAR-a deficient mice lasted longer than in wild-type mice ( 9 ).”
BackgroundKuwabara, K., Murakami, K., Todo, M., Aoki, T., Asaki, T., Murai, M., & Yano, J. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064659 · Cited by 37
Jones, D. C., Manning, B. M., & Daynes, R. A. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002173 · Cited by 39
“It is also appreciated that dysregulated PPAR activities are involved in a number of pathological states including cancer, inflammation, infertility, demylination and atherosclerosis (Devchand et al. 1996; Mueller et al. 2000; Berger & Moller, 2002; Takano & Komuro, 2002).”
BackgroundPrimary biliary cirrhosis in adults
Momah, N., & Lindor, K. D. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2014.888950 · Cited by 35
Lee, H.-J., Rao, J. S., Chang, L., Рапопорт, С. И., & Kim, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.117 · Cited by 35
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
Tovar‐Palacio, C., Torres, N., Díaz‐Villaseñor, A., & Tovar, A. R. (2012) · Genes & Nutrition · doi:10.1007/s12263-012-0295-5 · Cited by 35
“In addition, PPARa exerts antioxidant effects (Kono et al. 2009; Girnun et al. 2002; Diep et al. 2002; Devchand et al. 1996).”
Fatty Acids and Gene Expression Related to Inflammation
Calder, P. C. (2002) · KARGER eBooks · doi:10.1159/000067510 · Cited by 35
“appear to be regulated by, PUFAs and eicosanoids [56, 57].”
BackgroundInoue, I., Noji, S., Shen, M.-Z., Takahashi, K., & Katayama, S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7196 · Cited by 33
Hourton, D., Delerive, P., Staňková, J., Staels, B., Chapman, M. J., & Ninio, E. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540225 · Cited by 33
Nuclear Retinoid Receptors and Mechanisms of Action
Piedrafita, F. J., & Pfahl, M. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58483-1_5 · Cited by 37
Sex-Specific Differences in Type 2 Diabetes Mellitus and Dyslipidemia Therapy: PPAR Agonists
Benz, V., Kintscher, U., & Foryst‐Ludwig, A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_18 · Cited by 38
The role of PPAR activation during the systemic response to brain injury
Losey, P., Ladds, E. C., Laprais, M., Geuvel, B., Burns, L., Bordet, R., & Anthony, D. C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0295-7 · Cited by 32
Novel Antiinflammatory Targets for Asthma: A Role for PPAR γ ?
Serhan, C. N., & Devchand, P. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.f210 · Cited by 35
Self-citationDo sphingoid bases interact with the peroxisome proliferator activated receptor α (PPAR-α)?
Veldhoven, P. P. V., Mannaerts, G. P., Declercq, P. E., & Baes, M. I. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00092-9 · Cited by 32
Chinetti, G., & Staels, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.009 · Cited by 40
Peroxisome Proliferator-Activated Receptors and Atherosclerosis
Šoškić, S., Dobutović, B., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Zarić, B. L., Stojanović, S. Đ., Stokić, E., Mikhailidis, D. P., & Isenović, E. R. (2011) · Angiology · doi:10.1177/0003319711401012 · Cited by 33
From Basic Science to Clinical Applications
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., Rodeo, S. A., & Monica, S. (2009) · Cited by 32
Forest, C. D., Franckhauser, S., Glorian, M., Antras‐Ferry, J., Robin, D., & Robin, P. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90492-0 · Cited by 35
Gorla-Bajszczak, A., Juge-Aubry, C. E., Pernin, A., Burger, A., & Meier, C. A. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00217-2 · Cited by 32
Ppars: Nuclear Receptors for Fatty Acids Eicosanoids, and Xenobiotics
Devchand, P. R., IJpenberg, A., Devesvergne, B., & Wahli, W. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_34 · Cited by 32
Self-citationMichalik, L., Feige, J. N., Gelman, L., Pedrazzini, T., Keller, H., Desvergne, B., & Wahli, W. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0068 · Cited by 34
Self-citationArachidonic Acid Metabolites and the Kidney
Harris, R. C., Breyer, M. D., & BREYER, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10013-2 · Cited by 32
Adiponectin and Asthma: Knowns, Unknowns and Controversies
Oțelea, M. R., Arghir, O. C., Zugravu, C., & Rașcu, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168971 · Cited by 33
The Role of PPARs in the Endothelium: Implications for Cancer Therapy
Bishop‐Bailey, D., & Swales, K. E. (2008) · PPAR Research · doi:10.1155/2008/904251 · Cited by 31
“Supporting this, PPARα−/− mice exhibit enhanced inflammation [88], although this may be due in part to deceased β-oxidation and accumulation of biologically active lipid mediators.”
BackgroundTranscriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway
Lindström, T. M., & Bennett, P. R. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.003 · Cited by 31
Leukotriene modifiers in the treatment of cardiovascular diseases
Riccioni, G., Capra, V., D’Orazio, N., Bucciarelli, T., & Bazzano, L. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0808476 · Cited by 32
“Finally, LTs may play an important role in CVD, also acting as natural nuclear receptor ligands [ 20 ].”
BackgroundReview: Fibrates: therapeutic review
Chapman, M. J. (2006) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514060060010201 · Cited by 32
Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice
Goulet, J. L., Griffiths, R. C., Ruiz, P., Mannon, R. B., Flannery, P., Platt, J. L., Koller, B. H., & Coffman, T. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6631 · Cited by 33
Neurovascular protection by peroxisome proliferator-activated receptor α in ischemic stroke
Boese, A. C., Lee, J., & Hamblin, M. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113323 · Cited by 30
The Potential Role of PPARs in the Fetal Origins of Adult Disease
Guo, J., Wu, J., He, Q., Zhang, M., Li, H., & Liu, Y. (2022) · Cells · doi:10.3390/cells11213474 · Cited by 31
Emerging roles for eicosanoids in renal diseases
Câmara, N. O. S., Martins, J. O., Landgraf, R. G., & Jancar, S. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831a9df7 · Cited by 30
Flynn, M. A., Qiao, M., Garcia, C., Dallas, M., & Bonewald, L. F. (1999) · Calcified Tissue International · doi:10.1007/s002239900595 · Cited by 32
Lee, J., Chang, K., & Kim, G. (2009) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.3653 · Cited by 35
Raney, A. K., Kline, E. R., Tang, H., & McLachlan, A. (2001) · Virology · doi:10.1006/viro.2001.1169 · Cited by 30
Peroxisome Proliferator-Activated Receptor α (PPARα) down-regulation in cystic fibrosis lymphocytes
Reynders, V., Loitsch, S. M., Steinhauer, C., Wagner, T. O. F., Steinhilber, D., & Bargon, J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-104 · Cited by 30
“Inflammation induced by leukotriene B4, a PPARα ligand, has been reported to be prolonged in PPARα knock-out mice, suggesting an antiinflammatory role for PPARα [ 46 ].”
BackgroundIn vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
Stebbins, K. J., Broadhead, A. R., Cabrera, G., Correa, L. D., Messmer, D., Bundey, R. A., Baccei, C. S., Bravo, Y., Chen, A. C., Stock, N. S., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.008 · Cited by 30
Wang, G., & Namura, S. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.02.001 · Cited by 33
“PPAR null mice showed a prolonged inflammation in response to leukotriene B4 (Devchand et al., 1996).”
Background
Metadata
- Authors
- Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- National Institutes of Health (US)
- Venue
- Nature
- Published
- 1996-11
- Volume
- 384
- Issue
- 6604
- Pages
- 39-43
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1671834350
- Cited by
- 1,345
- References
- 43
- Citations by year
- 2026: 3 · 2025: 17 · 2024: 14 · 2023: 21 · 2022: 9 · 2021: 38 · 2020: 30 · 2019: 23 · 2018: 21 · 2017: 24 · 2016: 23 · 2015: 22 · 2014: 43 · 2013: 34 · 2012: 49
- FWCI
- 28.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- PPARα, leukotriene B4, inflammation, transcription factor activation, fatty acid oxidation, lipid mediators, chemotaxis, anti-inflammatory agents, liver, feedback regulation
- MeSH terms
- Adaptation, Physiological, Animals, Cells, Cultured, Fatty Acids, Female, Gene Expression Regulation, HeLa Cells, Humans, Inflammation, Leukotriene B4, Ligands, Liver, Male, Oxidation-Reduction, Plasmids, Pyrimidines, Time Factors, Transcription Factors, Transfection, Chloramphenicol O-Acetyltransferase, Arachidonic Acid, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.